Investigating lung disease risks after tuberculosis in people with and without HIV
Clinical and biologic risk factors for post-tuberculosis lung disease (PTLD) in people with and without HIV
This study is looking at how tuberculosis and HIV affect lung health in people, especially in sub-Saharan Africa, to help improve care for those dealing with post-tuberculosis lung disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10892976 on NIH RePORTER |
What this research studies
This research focuses on understanding the clinical and biological factors that contribute to post-tuberculosis lung disease (PTLD) in individuals, particularly in sub-Saharan Africa. The project aims to identify how tuberculosis and HIV interact to affect lung health, utilizing advanced research methods and mentorship from experts in the field. Patients may be involved in assessments that explore their health history and biological markers related to lung disease. The findings could lead to improved care strategies for those affected by tuberculosis and HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 years old who have a history of tuberculosis, with or without HIV.
Not a fit: Patients who have not been diagnosed with tuberculosis or do not have a history of lung disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for lung disease in individuals who have had tuberculosis, especially those living with HIV.
How similar studies have performed: Previous research has shown promising results in understanding the long-term effects of tuberculosis on lung health, indicating that this approach has potential for significant insights.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Zifodya, Jerry S. — Tulane University of Louisiana
- Study coordinator: Zifodya, Jerry S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.